Cocoon Biotech
Charles Koppel is an accomplished entrepreneur and investor with a diverse portfolio in health, wellness, and impact-driven ventures. As the Founder of Silklyfe, Koppel has developed a company that specializes in nature-inspired products using silk fibroin to enhance health and wellbeing. Koppel also serves as an Investor in multiple organizations, including Old Street Digital, which focuses on crypto asset advisory, Impact Hero, which integrates sustainability initiatives into businesses, and FYTA, catering to plant enthusiasts. Additionally, Koppel is the Chairman of Samco Investments Limited and holds the position of Investor and Director at Cocoon Biotech, where work is underway to create a drug delivery platform utilizing fibroin formulations.
This person is not in any teams
This person is not in any offices
Cocoon Biotech
Cocoon Biotech, Inc., was founded in 2013 to bring the freedom of living a healthy productive life to patients worldwide. Cocoon Biotech is developing a drug-delivery platform based on formulations of fibroin, a protein derived from the cocoon of the silkworm (Bombyx mori).